Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University
Takatsuki, Japan
Prof.Shin-Ichi Miyatake studied Medicine at the Kyoto University Medical School. He has been Professor at the Osaka Medical College in the Department of Neurosurgery and in the Cancer Center, and he is currently Professor at Kansai Medical BNCT Center in the Osaka Medical and Pharmaceutical University. He is member of several academic and professional societies, like the Japan Neurosurgical Society (board-certified Councilor), the Japan Society of Boron Neutron Capture Therapy (Councilor) and the The Society of Neuro-Oncology. He was president of 27th Japanese Society of Neuro-Oncology meeting and 6th Japanese Society of Neutron Capture Therapy meeting in 2009. He is also a member of the Board of Councilors of the ISNCT. His work in BNCT had been key for the development of the therapy and its use in a numerous number of patients. He was the principal investigator of company-lead, phase 1 and phase 2 trial of accelerator-based BNCT for recurrent malignant gliomas and the principal investigator of investigator-lead phase 2 trial of accelerator-based BNCT for recurrent and refractory high-grade meninigiomas. All of his work in BNCT enabled him to win 2014 the Hatanaka Award from 16th International Congress of Neutron Capture Therapy.
